Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Dermatology

Free Subscription 02.11.2026 1 Am J Dermatopathol 8 BMC Cancer 3 Br J Dermatol 2 Cancer Lett 1 Clin Dermatol 10 Clin Exp Dermatol 4 Cutis 10 Int J Dermatol 1 J Cutan Pathol 1 J Dermatol 13 J Invest Dermatol 2 JAAPA 1 Mycoses 3 Plast Reconstr Surg 1 PLoS Genet 1 PLoS Med 13 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. SOARES CARLONI Y, Arakaki Asato M, Alves Moares Neto F, Polizel Ocanha-Xavier J, et al
   Advanced Melanomas Are Not Prognostically Equal: A Proposal for Substratification.
   Am J Dermatopathol. 2026 Oct 30. doi: 10.1097/DAD.0000000000003427.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. ZHANG YJ, Liang ZM, Huang XY, Yu YJ, et al
   Pre-treatment prediction of response to neoadjuvant chemotherapy in breast cancer patients using a nomogram based on findings from cone-beam breast computed tomography.
   BMC Cancer. 2026;26:1318.
   PubMed         Abstract available
   
   
3. PRADO V, Esperanca G, Nahas GP, Maya BG, et al
   Metabolic health at breast cancer diagnosis and two-year survival: a prospective cohort study in a public healthcare setting.
   BMC Cancer. 2026;26:1309.
   PubMed         Abstract available
   
   
4. CONCATO-LOPES VM, Cruz EMS, de Lima LVA, Goncalves-Lens MD, et al
   The biphenyl dimeric compound 3,3',5,5'-tetramethoxybiphenyl-4,4'-diol disrupts redox homeostasis and mitochondrial function to inhibit growth and induce apoptosis in breast cancer monolayers and 3D tumor spheroids.
   BMC Cancer. 2026;26:1306.
   PubMed         Abstract available
   
   
5. ZHANG S, Xu L, Peng W
   A novel Hemoglobin-Albumin-Lymphocyte-Platelet (HALP)-based prognostic model to predict the progression of premenopausal breast cancer: a retrospective cohort study.
   BMC Cancer. 2026;26:1294.
   PubMed         Abstract available
   
   
6. WRIGHT FM, Vasileva-Slaveva M, Yordanov A, Ivanov I, et al
   Characterisation of a novel p53 mutation (p53(N263Tfs*7)) associated with li-fraumeni syndrome.
   BMC Cancer. 2026;26:1297.
   PubMed         Abstract available
   
   
7. ZHAO S, He S, Zhou Y, Fan Y, et al
   Clinicopathologic features and prognostic factors of breast cancer brain metastases patients based on molecular subtypes: a real-world retrospective analysis.
   BMC Cancer. 2026;26:1275.
   PubMed         Abstract available
   
   
8. CHANG X, Zuo S, Wang Z, Wang Z, et al
   Sleep patterns and breast cancer risk: a prospective cohort study integrating multi-omics and machine learning.
   BMC Cancer. 2026;26:1282.
   PubMed         Abstract available
   
   
9. ALABI A, Boateng F, Swanson W, Sowunmi A, et al
   Radiation therapy in breast cancer patients in south west Nigeria: an evaluation of protocols in a specialist cancer centre.
   BMC Cancer. 2026 Jul 10. doi: 10.1186/s12885-026-16483.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

10. HOPLEY GG, Walker SL
    Cercarial Dermatitis.
    Br J Dermatol. 2026 Oct 24:ljag479. doi: 10.1093.
    PubMed        
    
    
11. MCGRATH JA
    The Science of Skin Ageing Comes of Age: Molecular Insights, Precision Targets and Emerging Therapeutics.
    Br J Dermatol. 2026 Oct 26:ljag467. doi: 10.1093.
    PubMed        
    
    
12. LEONARD G, Emdin A, McSweeney SM, Smith C, et al
    Phenome-wide Longitudinal Association Study of Hospital-recorded Comorbidity in Psoriasis.
    Br J Dermatol. 2026 Oct 30:ljag450. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer Lett

13. DOMENICHINI M, Corsini M, Ravelli C, Ricci A, et al
    Oncogenic VEGFR2 rewires the extracellular matrix to impair endothelial mechanics and destabilize tumor vasculature.
    Cancer Lett. 2026;661:218848.
    PubMed         Abstract available
    
    
14. LI Y, Yuan B, Liu J, Wang X, et al
    PRMT1 and YBX1 Cooperatively Transcriptionally Activate GPX4 to Inhibit Ferroptosis and Promote Breast Cancer Progression.
    Cancer Lett. 2026 Sep 22:218849. doi: 10.1016/j.canlet.2026.218849.
    PubMed         Abstract available
    
    

    
    Clin Dermatol

15. 
    Melanoma risk in astronauts: Clinical screening, surveillance, and the microgravity paradox.
    Clin Dermatol. 2026 Oct 28:S0738-081X(26)00307.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

16. GORE A, Satchwell F, Odega E, Mehmood U, et al
    Unusual Sites of Cutaneous Ulceration.
    Clin Exp Dermatol. 2026 Oct 24:llag451. doi: 10.1093.
    PubMed        
    
    
17. SHARMA A, Mazumder R, Narang T, Handa S, et al
    Chronic Arsenic Toxicity Associated with Unregulated Complementary and Alternative Medicine Use in Psoriasis: A Case Series.
    Clin Exp Dermatol. 2026 Oct 27:llag454. doi: 10.1093.
    PubMed        
    
    
18. RAHMAN KL, McKenna K, Kearney N, McCann M, et al
    Vitamin D status and systemic inflammatory burden as a predictor of biologic treatment response in psoriasis -A pilot study in Northern Ireland.
    Clin Exp Dermatol. 2026 Oct 28:llag452. doi: 10.1093.
    PubMed         Abstract available
    
    
19. NAYEE S, Craythorne E, Naik H, Harrison M, et al
    Lip and oral involvement in 116 patients with xeroderma pigmentosum in the UK.
    Clin Exp Dermatol. 2026;51:2069-2073.
    PubMed         Abstract available
    
    
20. TONELLA VEZZOLI R
    Acne, mental health and isotretinoin: disentangling disease burden, treatment effects and psychiatric risk.
    Clin Exp Dermatol. 2026;51:1983-1990.
    PubMed         Abstract available
    
    
21. DAZA-GARCIA R, Garcia-Nunez A, Alcala Ramirez Del Puerto A, Pereyra-Rodriguez JJ, et al
    Long-term persistence of baricitinib in alopecia areata: a real-world pharmacy-based cohort study.
    Clin Exp Dermatol. 2026;51:2066-2068.
    PubMed         Abstract available
    
    
22. FRANZ A, Constantinou A, Wilborn D, Krokowski I, et al
    The follicular microbiome in hair-follicle-associated inflammatory diseases: a systematic review.
    Clin Exp Dermatol. 2026;51:2013-2025.
    PubMed         Abstract available
    
    
23. WANG SH, Liu SH, Zhang J, Zhang H, et al
    Real-world outcomes of stapokibart-based combination therapy for bullous pemphigoid: a single-centre retrospective cohort.
    Clin Exp Dermatol. 2026;51:2034-2042.
    PubMed         Abstract available
    
    
24. KWATRA SG, Kim BS, Bewley A, Elmariah SB, et al
    The evolving understanding of prurigo nodularis.
    Clin Exp Dermatol. 2026;51:2001-2012.
    PubMed         Abstract available
    
    
25. AL-SHARBATEE G, Daruish M, Wu D, Taibjee S, et al
    Utility of p53 immunohistochemistry in atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective study of 50 patients.
    Clin Exp Dermatol. 2026;51:2060-2065.
    PubMed         Abstract available
    
    

    
    Cutis

26. URBAN K, Ho D, Shitabata P, Nami N, et al
    Kratom: An Emerging Cause of Drug-Induced Hyperpigmentation.
    Cutis. 2026;118:82-84.
    PubMed         Abstract available
    
    
27. ZHENG L, Reeder M, Atwater AR, Yu J, et al
    Benzyl Alcohol: The 2026 American Contact Dermatitis Society Allergen of the Year.
    Cutis. 2026;118:88-91.
    PubMed         Abstract available
    
    
28. BLACKWOOD JD, Pride HB, Kondratuk KE
    Expanding Access to Pediatric Dermatology Through Store-and-Forward Teledermatology.
    Cutis. 2026;118:95-98.
    PubMed         Abstract available
    
    
29. DESIR N, Encarnacion IN, Durango KP, Obeng-Nyarko C, et al
    Hidradenitis Suppurativa-Associated Squamous Cell Carcinoma of the Groin: A Clinicopathologic Analysis.
    Cutis. 2026;118:92-98.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

30. BALAN K, Tatar D
    Beyond Classical Atopic Dermatitis: Rethinking Head-Neck Flares in the Era of Targeted Therapies.
    Int J Dermatol. 2026 Oct 23. doi: 10.1111/ijd.70763.
    PubMed        
    
    
31. SHIRE S, Ayub A, Dulmage B
    Skin Tone Representation in Dermatologic Images of a Board Preparation Resource: A Multi-Edition Content Analysis.
    Int J Dermatol. 2026 Oct 23. doi: 10.1111/ijd.70738.
    PubMed        
    
    
32. PAOLINO G, Carugno A, Mercuri SR, Rizzo N, et al
    Lymphomatoid Papulosis-Like Lymphoid Reaction During Dupilumab Therapy for Atopic Dermatitis.
    Int J Dermatol. 2026 Oct 23. doi: 10.1111/ijd.70759.
    PubMed        
    
    
33. DURDU M, Karacan MM, Uzun S
    Multiple Pruritic Penile Papules and Nodules as a Highly Specific Clinical Sign of Scabies in Men Patients: A Two-Center Retrospective Study.
    Int J Dermatol. 2026 Oct 24. doi: 10.1111/ijd.70757.
    PubMed        
    
    
34. SHAVIT E
    Moving Beyond the Breslow Thickness Threshold: Can Dynamic Indices Refine Risk Assessment in Thin Melanoma?
    Int J Dermatol. 2026 Oct 22. doi: 10.1111/ijd.70748.
    PubMed        
    
    
35. SPADAFORA M, Palmisano G, Conforti C, Ambrosio L, et al
    The Role of Line-Field Confocal Optical Coherence Tomography in the Diagnosis of Melanoma and Melanocytic Lesions: A Systematic Review.
    Int J Dermatol. 2026 Oct 23. doi: 10.1111/ijd.70736.
    PubMed         Abstract available
    
    
36. BOYLAN N, Boyd G, Kearney N, McKenna K, et al
    Exploring Factors That Predict 'Super Response' to Biologic Therapy in Psoriasis.
    Int J Dermatol. 2026 Oct 25. doi: 10.1111/ijd.70740.
    PubMed        
    
    
37. GUEVARA BEK, Wright AK, Ceballos RF, De Guzman J, et al
    Understanding the Impact of Living With Psoriasis in the Philippines: A Global Psoriasis Atlas Online Survey.
    Int J Dermatol. 2026 Oct 25. doi: 10.1111/ijd.70750.
    PubMed         Abstract available
    
    
38. MENDES SILVA LEGA JP, Zicatti de Silveira AC, Miyaguchi ETB, de Castro Barroti L, et al
    Bullous Cutaneous Amyloidosis as the Initial Manifestation of Multiple Myeloma: A Case Report.
    Int J Dermatol. 2026 Oct 26. doi: 10.1111/ijd.70754.
    PubMed         Abstract available
    
    
39. LEAL MERIDA M, Perea Polak A, Cornax Martin ME, Nieto Vallejo SM, et al
    Targeting Type 2 Pathway in Refractory Dermatitis Herpetiformis: Rapid Response to Dupilumab in a Patient Unable to Receive Dapsone.
    Int J Dermatol. 2026 Oct 29. doi: 10.1111/ijd.70769.
    PubMed        
    
    

    
    J Cutan Pathol

40. WANG SK, George D, Ring N, Dainiak N, et al
    NTRK1-Rearranged Cutaneous Non-Langerhans Cell Histiocytosis With Durable Response to TRK Inhibitor in a Patient With Primary Myelofibrosis.
    J Cutan Pathol. 2026 Oct 28. doi: 10.1111/cup.70224.
    PubMed         Abstract available
    
    

    
    J Dermatol

41. SU YJ, Shao YJ, Chang CL, Hwang DK, et al
    Risk of Cataract and Its Association With Phototherapy Among Patients With Psoriasis.
    J Dermatol. 2026 Oct 26. doi: 10.1111/1346-8138.70552.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

42. HEISKANEN L, Nissinen L, Siljamaki E, Rappu P, et al
    C3a/C3aR1 axis promotes invasion of cutaneous squamous cell carcinoma and is associated with metastasis and poor prognosis.
    J Invest Dermatol. 2026 Oct 30:S0022-202X(26)03796.
    PubMed         Abstract available
    
    
43. TILLEY L, Shwartz Y
    An anatomical framework for cutaneous sympathetic organization in mice reveals overlapping ganglionic territories and long-range stellate projections.
    J Invest Dermatol. 2026 Oct 30:S0022-202X(26)03799.
    PubMed         Abstract available
    
    
44. CHEN LY, Liao CP, Weng HJ, Tai YH, et al
    Systemic immune dysregulation in neurofibromatosis type 1: Translational validation of atopic multimorbidity.
    J Invest Dermatol. 2026;146:3033-3043.
    PubMed         Abstract available
    
    
45. BRITO NUNES C, Simpson MA, Moen GH, Mitchell BL, et al
    Dissecting the causal links between acne vulgaris and cardiometabolic health using Mendelian randomization.
    J Invest Dermatol. 2026;146:3025-3032.
    PubMed         Abstract available
    
    
46. WU WC, Gandhi Sethuraman MI, Tong TK, Ng HL, et al
    Selective blockade of gammac pathway ameliorates alopecia areata in a humanized murine model.
    J Invest Dermatol. 2026;146:3127-3141.
    PubMed         Abstract available
    
    
47. KHAIR LG, Sarig O, Ishtewy RF, Malovitski K, et al
    An ITGB4 variant modifies the severity of ITGA3-associated interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa (ILNEB).
    J Invest Dermatol. 2026;146:3102-3111.
    PubMed         Abstract available
    
    
48. WEBER M, Ackermann A, Li MY, Meehan SA, et al
    Mouse model of Merkel cell carcinoma derived from the hair follicle.
    J Invest Dermatol. 2026;146:3054-3066.
    PubMed         Abstract available
    
    
49. TO TT, Deng M, Andrade PR, Nguyen NPN, et al
    Cutibacterium acnes induces T-cell extracellular traps with distinct proteome programs.
    J Invest Dermatol. 2026;146:3011-3024.
    PubMed         Abstract available
    
    
50. MAHO-VAILLANT M, Lefebvre A, Golinski ML, Calbo S, et al
    Daratumumab as a therapeutic option for rituximab-recalcitrant pemphigus.
    J Invest Dermatol. 2026;146:3044-3053.
    PubMed         Abstract available
    
    
51. OEY HM, Kao YC, Lee KJ, Zhou C, et al
    The genomic and spatial transcriptomic landscape of seborrheic keratoses.
    J Invest Dermatol. 2026;146:3155-3161.
    PubMed         Abstract available
    
    
52. HOVNANIAN A, Mondon G, Titeux M
    History and future of RNA medicines.
    J Invest Dermatol. 2026;146:2984-2998.
    PubMed         Abstract available
    
    
53. LI W, Sun K, Huang J, Han X, et al
    Updates on endothelial injury in dermatomyositis: Clinical correlations and potential mechanisms.
    J Invest Dermatol. 2026;146:2973-2983.
    PubMed         Abstract available
    
    
54. SHEN CZ, Shon D, Kuo Y, Ellebrecht CT, et al
    Chimeric antigen receptor T-cell therapy in dermatologic autoimmunity: Mechanisms, applications, and future directions.
    J Invest Dermatol. 2026;146:2999-3010.
    PubMed         Abstract available
    
    

    
    JAAPA

55. HULSEY B, Walker CW, McFarlane A
    Atopic dermatitis.
    JAAPA. 2026;39:29-35.
    PubMed         Abstract available
    
    
56. YOUNG E
    Digital breast tomosynthesis: A new standard of care for breast cancer screening?
    JAAPA. 2026;39:e1-e5.
    PubMed         Abstract available
    
    

    
    Mycoses

57. LI J, Wu H, Li Y, Li R, et al
    Between Skin and Brain: A Systematic Review of 712 Cases 1976-2025 Reveals a Highly Diverse Disease Spectrum in Chaetothyriales.
    Mycoses. 2026;69:e70234.
    PubMed         Abstract available
    
    

    
    Plast Reconstr Surg

58. HOLT-KEDDE IL, Sadok N, Kuikhoven M, Schoder CP, et al
    Beyond Body Mass Index: Subcutaneous Adipose Tissue and Smoking History as Predictors of Postoperative Complications in DIEP Flap Breast Reconstruction.
    Plast Reconstr Surg. 2026;158:771e-781e.
    PubMed         Abstract available
    
    
59. DADZIE AI, Rossman A, Hansen K, Gardner M, et al
    An Analysis of the Timing of Autologous Breast Reconstruction after Mastectomy and Radiotherapy.
    Plast Reconstr Surg. 2026;158:755e-764e.
    PubMed         Abstract available
    
    
60. PATEL V, Quick J, Wu S, Schafer R, et al
    Safety of Hormonal Therapy Prior to DIEP Reconstruction: A Matched Cohort Analysis.
    Plast Reconstr Surg. 2026;158:713-719.
    PubMed         Abstract available
    
    

    
    PLoS Genet

61. MUSICK M, Ufondu CA, Rowland CE, Brown ME, et al
    CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells.
    PLoS Genet. 2026;22:e1012351.
    PubMed         Abstract available
    
    

    
    PLoS Med

62. STAROWICZ K
    Breast cancer treatment: When less is more.
    PLoS Med. 2026;23:e1005284.
    PubMed         Abstract available
    
    

    
    PLoS One

63. STANBURY K, Cassarani MP, Boyle JP, Schofield E, et al
    Genetic characterization of a canine model of human GAPO syndrome caused by a nonsense variant in ANTXR1.
    PLoS One. 2026;21:e0359081.
    PubMed         Abstract available
    
    
64. JUTAGIR DR, Espinosa A, Lopez M, Claros M, et al
    Identifying barriers to immunotherapy access for triple-negative breast cancer: A qualitative analysis of interviews with medical oncologists.
    PLoS One. 2026;21:e0361021.
    PubMed         Abstract available
    
    
65. HUANG S, Li Y
    Cross-platform comparison of diabetic foot ulcer transcriptomes identifies partially concordant disease-associated signals.
    PLoS One. 2026;21:e0356328.
    PubMed         Abstract available
    
    
66. ZAMANI SHIVA Y, Hasandoost F, Nasiri M, Mahvar T, et al
    Association of a structured prevention algorithm with nurse knowledge and device-related pressure injury severity in critical care: A pre?post study.
    PLoS One. 2026;21:e0359842.
    PubMed         Abstract available
    
    
67. CASTILLO H, Sebio-Garcia R, Martinez-Palli G, Siso M, et al
    Multimodal lifestyle intervention during neoadjuvant chemotherapy in patients with early breast cancer as a strategy to improve treatment response: Protocol of the DIANA randomized clinical trial.
    PLoS One. 2026;21:e0361188.
    PubMed         Abstract available
    
    
68. WANG YH, Aggarwal A, Davies EA
    Disparities in screening participation and stage at diagnosis for breast and bowel cancers among individuals with pre-existing mental health disorders: A population-based study.
    PLoS One. 2026;21:e0361617.
    PubMed         Abstract available
    
    
69. DEGERMAN M, Bertilson BC, Ohman M, Corneliusson L, et al
    Can Photobiomodulation improve healing of category II-III pressure ulcers in frail older adults? A quasi-experimental 24-month follow-up study.
    PLoS One. 2026;21:e0359780.
    PubMed         Abstract available
    
    
70. CHENG Y, Jia L, Sheng L, Han X, et al
    TRPM7 modulates endothelial cell functions and VEGFA-associated signaling in diabetic foot.
    PLoS One. 2026;21:e0359834.
    PubMed         Abstract available
    
    
71. SILVA PVS, Silva LGSD, Cruz ACDC, Cavalcante Junior AG, et al
    Spatial distribution of the time between diagnosis and treatment of breast cancer among women in Brazil.
    PLoS One. 2026;21:e0361469.
    PubMed         Abstract available
    
    
72. DONG L, Liu C, Li L, Zhang X, et al
    Study on the association between the low-density lipoprotein to high-density lipoprotein ratio and clinicopathological characteristics of breast cancer: A retrospective analysis incorporating subgroup evaluations by age, body mass index, and menopausa
    PLoS One. 2026;21:e0361764.
    PubMed         Abstract available
    
    
73. DAS S, Patra S, Om S, Kundu S, et al
    Reported clinical breast examination activity in Bangladesh, 2019-2025: Temporal trends, geographic variation, positivity, and reporting completeness.
    PLoS One. 2026;21:e0361910.
    PubMed         Abstract available
    
    
74. BAIDOO D
    Multi-dimensional structure and subtype-specific heterogeneity of angiogenesis in breast cancer.
    PLoS One. 2026;21:e0348390.
    PubMed         Abstract available
    
    
75. CHIANG JK, Chiang PC, Koo M
    Electronic health record phenotype choice and real-world outcome estimates: A propensity score-matched comparison of three invasive breast cancer definitions in TriNetX.
    PLoS One. 2026;21:e0361883.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

76. JIMENEZ-ANDRADE Y, Sol S, Yoshida T, Tran M, et al
    The staphylococcal protease SspA perturbs the epidermal barrier and promotes IL-22-driven inflammation in allergen-exposed skin.
    Proc Natl Acad Sci U S A. 2026;123:e2611563123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum